While there have been previous reports of IMC induced by PD-1 inhibitors, there have been no documented cases of IMC, intestinal obstruction or hemorrhage of the digestive tract caused by sintilimab simultaneously. This evidence concerns the gene PDCD1 and intestinal obstruction.